INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 84 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 6.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $281,000 | -7.3% | 44,381 | +14.7% | 0.00% | 0.0% |
| Q2 2017 | $303,000 | +18.4% | 38,692 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $256,000 | -11.7% | 38,692 | -7.3% | 0.00% | 0.0% |
| Q4 2016 | $290,000 | -28.7% | 41,750 | -4.4% | 0.00% | -50.0% |
| Q3 2016 | $407,000 | +0.7% | 43,673 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $404,000 | -2.2% | 43,673 | -4.6% | 0.00% | 0.0% |
| Q1 2016 | $413,000 | +29.9% | 45,779 | -3.3% | 0.00% | +100.0% |
| Q4 2015 | $318,000 | +18.2% | 47,329 | +1.7% | 0.00% | 0.0% |
| Q3 2015 | $269,000 | -29.2% | 46,517 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $380,000 | +6.4% | 46,517 | +6.3% | 0.00% | +100.0% |
| Q1 2015 | $357,000 | -14.8% | 43,743 | -4.1% | 0.00% | -50.0% |
| Q4 2014 | $419,000 | -8.3% | 45,597 | -1.7% | 0.00% | 0.0% |
| Q3 2014 | $457,000 | -8.8% | 46,382 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $501,000 | – | 46,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|